0000902664-23-001847.txt : 20230215
0000902664-23-001847.hdr.sgml : 20230215
20230215101120
ACCESSION NUMBER: 0000902664-23-001847
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230213
FILED AS OF DATE: 20230215
DATE AS OF CHANGE: 20230215
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kepos Capital LP
CENTRAL INDEX KEY: 0001512020
STATE OF INCORPORATION: DE
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40915
FILM NUMBER: 23633984
BUSINESS ADDRESS:
STREET 1: 11 TIMES SQUARE, 35TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10036
BUSINESS PHONE: 212-588-7400
MAIL ADDRESS:
STREET 1: 11 TIMES SQUARE, 35TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10036
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PepperLime Health Acquisition Corp
CENTRAL INDEX KEY: 0001873324
STANDARD INDUSTRIAL CLASSIFICATION: BLANK CHECKS [6770]
IRS NUMBER: 000000000
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 548 MARKET STREET
STREET 2: PMB 97425
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
BUSINESS PHONE: (415) 263-9939
MAIL ADDRESS:
STREET 1: 548 MARKET STREET
STREET 2: PMB 97425
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
4
1
ownership.xml
X0306
4
2023-02-13
1
0001873324
PepperLime Health Acquisition Corp
PEPL
0001512020
Kepos Capital LP
11 TIMES SQUARE, 35TH FLOOR
NEW YORK
NY
10036
0
0
1
0
Class A Ordinary Shares, par value $0.0001 per share
2023-02-13
4
S
0
100000
10.1408
D
86348
I
See footnote
The securities to which this filing relates are held directly by certain funds (the "Kepos Funds") to which Kepos Capital LP (the "Investment Manager"), a Delaware limited partnership, serves as investment manager. Mr. Mark Carhart ("Mr. Carhart") is the managing member of Kepos Capital GP LLC, the general partner of the Investment Manager. The Investment Manager and Mr. Carhart disclaim beneficial ownership of the Issuer's securities reported herein except to the extent of its or his pecuniary interest therein, if any.
Kepos Capital LP, By: /s/ Simon Raykher, General Counsel
2023-02-15
Mark Carhart, /s/ Mark Carhart
2023-02-15